| Year |
Citation |
Score |
| 2024 |
He RN, Zhang MJ, Dai B, Kong XD. Selection of Peptide-Bismuth Bicycles Using Phage Display. Acs Chemical Biology. PMID 38620022 DOI: 10.1021/acschembio.4c00099 |
0.646 |
|
| 2021 |
Carle V, Kong XD, Comberlato A, Edwards C, Díaz-Perlas C, Heinis C. Generation of a 100-billion cyclic peptide phage display library having a high skeletal diversity. Protein Engineering, Design & Selection : Peds. 34. PMID 34341825 DOI: 10.1093/protein/gzab018 |
0.739 |
|
| 2021 |
Kong XD, Heinis C. Towards the Development of Orally Available Peptide Therapeutics. Chimia. 75: 514-517. PMID 34233815 DOI: 10.2533/chimia.2021.514 |
0.711 |
|
| 2021 |
Stevens CA, Bachtiger F, Kong XD, Abriata LA, Sosso GC, Gibson MI, Klok HA. A minimalistic cyclic ice-binding peptide from phage display. Nature Communications. 12: 2675. PMID 33976148 DOI: 10.1038/s41467-021-22883-w |
0.364 |
|
| 2021 |
Carle V, Wu Y, Mukherjee R, Kong XD, Rogg C, Laurent Q, Cecere E, Villequey C, Konakalla MS, Maric T, Lamers C, Díaz-Perlas C, Butler K, Goto J, Stegmayr B, et al. Development of Selective FXIa Inhibitors Based on Cyclic Peptides and Their Application for Safe Anticoagulation. Journal of Medicinal Chemistry. PMID 33974422 DOI: 10.1021/acs.jmedchem.1c00056 |
0.706 |
|
| 2020 |
Kong XD, Carle V, Díaz-Perlas C, Butler K, Heinis C. Generation of a Large Peptide Phage Display Library by Self-Ligation of Whole-Plasmid PCR Product. Acs Chemical Biology. PMID 33125222 DOI: 10.1021/acschembio.0c00497 |
0.701 |
|
| 2020 |
Wilbs J, Kong XD, Middendorp SJ, Prince R, Cooke A, Demarest CT, Abdelhafez MM, Roberts K, Umei N, Gonschorek P, Lamers C, Deyle K, Rieben R, Cook KE, Angelillo-Scherrer A, et al. Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs. Nature Communications. 11: 3890. PMID 32753636 DOI: 10.1038/S41467-020-17648-W |
0.628 |
|
| 2020 |
Kong X, Moriya J, Carle V, Pojer F, Abriata LA, Deyle K, Heinis C. De novo development of proteolytically resistant therapeutic peptides for oral administration Nature Biomedical Engineering. 4: 560-571. PMID 32393891 DOI: 10.1038/S41551-020-0556-3 |
0.721 |
|
| 2019 |
Maola K, Wilbs J, Touati J, Sabisz M, Kong X, Baumann A, Deyle K, Heinis C. Engineered Peptide Macrocycles Can Inhibit Matrix Metalloproteinases with High Selectivity Angewandte Chemie. 58: 11801-11805. PMID 31251434 DOI: 10.1002/Anie.201906791 |
0.646 |
|
| 2018 |
Kale SS, Villequey C, Kong XD, Zorzi A, Deyle K, Heinis C. Cyclization of peptides with two chemical bridges affords large scaffold diversities. Nature Chemistry. PMID 29713035 DOI: 10.1038/S41557-018-0042-7 |
0.68 |
|
| 2017 |
Villequey C, Kong XD, Heinis C. Bypassing bacterial infection in phage display by sequencing DNA released from phage particles. Protein Engineering, Design & Selection : Peds. 30: 761-768. PMID 29194551 DOI: 10.1093/protein/gzx057 |
0.541 |
|
| 2017 |
Deyle K, Kong XD, Heinis C. Phage Selection of Cyclic Peptides for Application in Research and Drug Development. Accounts of Chemical Research. PMID 28719188 DOI: 10.1021/Acs.Accounts.7B00184 |
0.743 |
|
| 2017 |
Liu W, Zheng Y, Kong X, Heinis C, Zhao Y, Wu C. Precisely Regulated and Efficient Locking of Linear Peptides into Stable Multicyclic Topologies through a One-Pot Reaction. Angewandte Chemie (International Ed. in English). PMID 28240444 DOI: 10.1002/anie.201610942 |
0.721 |
|
| Show low-probability matches. |